{"id":61783,"date":"2025-08-28T16:05:26","date_gmt":"2025-08-28T14:05:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/"},"modified":"2025-08-28T16:05:26","modified_gmt":"2025-08-28T14:05:26","slug":"hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/","title":{"rendered":"Hammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity"},"content":{"rendered":"
\n

\nHammes Partners announced the closing of $445 million in equity commitments for its core-plus healthcare real estate platform \u2014building on a history of institutional investment in healthcare real estate.<\/i><\/p>\n

MILWAUKEE–(BUSINESS WIRE)–Hammes Partners, one of the leading institutional investment management firms focused on the U.S. healthcare real estate market, announced the successful closing of $445 million in equity for its core-plus healthcare real estate platform. Hammes significantly exceeded its target of $350 million, securing $445 million in equity commitments from a diverse base of institutional investors. The firm plans to continue to scale its core-plus platform over time.<\/p>\n

<\/a>
<\/a><\/p>\n

\n“We are grateful for the strong support from new investors as well as returning investors that remain confident in our investment strategy and track record,” said Patrick Hammes, Managing Principal of Hammes Partners. “We believe this platform will enable us to provide our investors with exposure to quality, highly stabilized U.S. healthcare real estate assets while supporting the facility objectives of our healthcare provider partners nationwide.”<\/p>\n

\nThe new core-plus initiative will focus on investments in healthcare facilities that have resilient and predictable cash flows. Leveraging approximately 25 years of investment experience and drawing on its roots as an operator, the initiative will target well-positioned facilities that are integral to the real estate footprints of leading healthcare providers.<\/p>\n

\nAs part of a national, vertically integrated healthcare real estate platform, Hammes Partners is complemented by the suite of services offered by its affiliates, including Hammes Healthcare and Hammes Realty Services. Hammes Healthcare is a nationally recognized leader in healthcare real estate consulting and project delivery while Hammes Realty Services provides comprehensive property management services.<\/p>\n

\nAlston & Bird, LLP served as legal counsel in the formation of the fund.<\/p>\n

\nAbout Hammes Partners<\/b><\/p>\n

\nHammes Partners is a private investment platform focused exclusively on the U.S. healthcare real estate market, including investments in existing assets, entitled development projects and adaptive reuse opportunities.<\/p>\n

\nThe Hammes platform has been recognized as one of the nation\u2019s leading healthcare developers by Modern Healthcare\u2019s Construction & Design Survey for 27 consecutive years\u2014including 21 years as No. 1\u2014 and by Revista\u2019s Outpatient Healthcare Real Estate Development Report.<\/p>\n

\nHeadquartered in Milwaukee, Wisconsin, Hammes provides services through a network of regional offices strategically located across the United States. For more information, please visit www.hammespartners.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:<\/b>
Katherine Murray
\n
Vice President of Marketing, Hammes
\n
kmurray@hammes.com<\/a>
(414) 509-2595<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Hammes Partners announced the closing of $445 million in equity commitments for its core-plus healthcare real estate platform \u2014building on a history of institutional investment in healthcare real estate. MILWAUKEE–(BUSINESS WIRE)–Hammes Partners, one of the leading institutional investment management firms focused on the U.S. healthcare real estate market, announced the successful closing of $445 million … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61783","6":"format-standard","7":"category-industry"},"yoast_head":"\nHammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Hammes Partners announced the closing of $445 million in equity commitments for its core-plus healthcare real estate platform \u2014building on a history of institutional investment in healthcare real estate. MILWAUKEE–(BUSINESS WIRE)–Hammes Partners, one of the leading institutional investment management firms focused on the U.S. healthcare real estate market, announced the successful closing of $445 million ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T14:05:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250828778100\/en\/2564254\/22\/HAMMES_LOGO_TYPE-PARTNERS_RGB_NAVY.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Hammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity\",\"datePublished\":\"2025-08-28T14:05:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/\"},\"wordCount\":409,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250828778100\\\/en\\\/2564254\\\/22\\\/HAMMES_LOGO_TYPE-PARTNERS_RGB_NAVY.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/\",\"name\":\"Hammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250828778100\\\/en\\\/2564254\\\/22\\\/HAMMES_LOGO_TYPE-PARTNERS_RGB_NAVY.jpg\",\"datePublished\":\"2025-08-28T14:05:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250828778100\\\/en\\\/2564254\\\/22\\\/HAMMES_LOGO_TYPE-PARTNERS_RGB_NAVY.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250828778100\\\/en\\\/2564254\\\/22\\\/HAMMES_LOGO_TYPE-PARTNERS_RGB_NAVY.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/","og_locale":"en_US","og_type":"article","og_title":"Hammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity - Pharma Trend","og_description":"Hammes Partners announced the closing of $445 million in equity commitments for its core-plus healthcare real estate platform \u2014building on a history of institutional investment in healthcare real estate. MILWAUKEE–(BUSINESS WIRE)–Hammes Partners, one of the leading institutional investment management firms focused on the U.S. healthcare real estate market, announced the successful closing of $445 million ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-28T14:05:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250828778100\/en\/2564254\/22\/HAMMES_LOGO_TYPE-PARTNERS_RGB_NAVY.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Hammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity","datePublished":"2025-08-28T14:05:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/"},"wordCount":409,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250828778100\/en\/2564254\/22\/HAMMES_LOGO_TYPE-PARTNERS_RGB_NAVY.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/","url":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/","name":"Hammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250828778100\/en\/2564254\/22\/HAMMES_LOGO_TYPE-PARTNERS_RGB_NAVY.jpg","datePublished":"2025-08-28T14:05:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250828778100\/en\/2564254\/22\/HAMMES_LOGO_TYPE-PARTNERS_RGB_NAVY.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250828778100\/en\/2564254\/22\/HAMMES_LOGO_TYPE-PARTNERS_RGB_NAVY.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/hammes-partners-exceeds-target-for-core-plus-healthcare-real-estate-initiative-closing-445-million-in-equity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hammes Partners Exceeds Target for Core-Plus Healthcare Real Estate Initiative Closing $445 Million in Equity"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61783"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61783\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}